Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Pfizer
Business Segments
Products & Services
Deferred revenues
Deferred revenues
Pfizer
·
Products & Services
·
1 segment
·
Rolls up to
Contract Liabilities
Breakdown
Segments
Paxlovid and Comirnaty
View metric
Quarterly
Annual
TTM
Segment
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Paxlovid and Comirnaty
$4.3B
$3.5B
$2.2B
$1.9B
$1.9B
$1.8B
$1.5B
$1.5B
Total
—
—
—
—
—
—
—
—